Medtronic Stock News

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front, the Food and Drug A

Medtronic (NYSE:MDT) is scheduled to announce Q3 earnings results on Tuesday, Feb. 22, before market open.The consensus EPS estimate is $1.37 (+6.2% Y/Y)

© Reuters. FILE PHOTO – An empty bed is pictured at the Children’s Hospital of Georgia in Augusta, Georgia, U.S., January 14, 2022. REUTERS/Hannah Beier By Amruta Khandekar (Reuters) – Steady sales of pacemakers and heart stents may have likely helped Medtronic (NYSE:) Plc offset weak demand for its other medical devices, in a quarter …

The FDA has approved Medtronic plc''s (NYSE: MDT ) Freezor and Freezor Xtra Cardiac Cryoablation Catheters to treat pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT). The Freezor and Freezor Xtra Catheters are flexible, single-use devices to freeze cardiac tissue and block … Full story available on Benzinga.com

Medtronic (MDT) announced on Friday that the U.S. Food and Drug Administration ((FDA)) approved Freezor and Freezor Xtra Cardiac Cryoablation Catheters for pediatric use in a common…

By Amruta Khandekar (Reuters) – Steady sales of pacemakers and heart stents may have likely helped Medtronic Plc offset weak demand for its other medical devices, in a quarter that saw an Omicron-led surge in COVID-19 cases and staffing crisis at most U.S. hospitals.

DUBLIN, Feb. 18, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the Freezor™ and Freezor™ Xtra Cardiac Cryoablation Catheters are approved by the U.S. Food and Drug Administration (FDA) and are the only ablation catheters…

Medtronic (MDT) might report low procedure volumes in the fiscal third quarter in markets where its technologies are used in more deferrable procedures.

Medtronic''s heart device unit may ease earnings pressure from Omicron

Although U.S. markets are closed Monday for President''s Day, two energy firms will release earnings on Monday. Three more firms are on deck to report results Tuesday morning.

Steady sales of pacemakers and heart stents may have likely helped Medtronic Plc offset weak demand for its other medical devices, in a quarter that saw an Omicron-led surge in COVID-19 cases and staf

2 Crushed Dividend Champions Worth Saving

Medtronic stock is scheduled to report its fiscal third-quarter results on Tuesday, Feb 22. We expect Medtronic to post revenues and earnings above the consensus estimates.

Exclusive: chair of standards committee calls for power to shut down APPGs where there are clear conflicts of interest More than £13m has been poured into a growing network of MPs’ interest groups by private firms including healthcare bodies, arms companies and tech giants, fuelling concerns over the potential for backdoor influence. Analysis by the Guardian and Open Democracy found that more than half the total £25m in funding for all-party parliamentary groups (APPGs) since 2018 has come from the private sector. The obesity APPG, which has sought to promote medical interventions for obesity, received £178,500 to £183,000 between 2019 and 2021 from three private healthcare companies that make or promote gastric bands or drugs used in obesity surgery and treatment: Johnson & Johnson, Medtronic and Novo Nordisk. The support was used to pay for a lobbyist, HealthComms Consulting, to run the APPG’s secretariat. The lobbyist says on its website that the APPG promoted calls for “a shift away from the ‘move more, eat less’ mentality prevalent in obesity thinking and better utilisation of treatment for obesity and access to services”.

Pune, Feb. 17, 2022 (GLOBE NEWSWIRE) -- " Final Report will add the analysis of the impact of COVID-19 on this industry. " Global " Spinal Implants and Surgery Devices Market " is a comprehensive research that provides information regarding Spinal Implants and Surgery Devices market size, trends, growth, cost structure, capacity, revenue, and forecast for 2027. This report also includes the overall study of the Spinal Implants and Surgery Devices Market share with all its aspects influencing the growth of the market. This report is exhaustive quantitative analyses of the Spinal Implants and Surgery Devices industry and provides data for making strategies to increase Spinal Implants and Surgery Devices market growth and effectiveness. The report further investigates and assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the Spinal Implants and Surgery Devices market. The global Spinal Implants and Surgery Devices market size is projected to reach US$ 13440 million by 2027, from US$ 9529.7 million in 2020, at a CAGR of 5.0% during 2021-2027.